share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4:持股變動聲明-董事 Burrell Terry-Ann
美股SEC公告 ·  07/03 16:41
Moomoo AI 已提取核心訊息
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on July 1, 2024. The transaction involved a grant of 1,843 shares of Class A Common Stock at no cost. Following the transaction, Burrell's direct holdings in the company increased to a total of 71,254 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on July 1, 2024. The transaction involved a grant of 1,843 shares of Class A Common Stock at no cost. Following the transaction, Burrell's direct holdings in the company increased to a total of 71,254 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell,Recursion藥品公司[RXRX]的相關人員,於2024年7月1日完成了股票收購。該交易涉及免費授予1,843股A類普通股。交易後,Burrell在公司中的直接持股數量增至總共71,254股。該授予是公司股票激勵計劃的一部分,反映了將員工利益與股東利益保持一致的持續承諾。
Terry-Ann Burrell,Recursion藥品公司[RXRX]的相關人員,於2024年7月1日完成了股票收購。該交易涉及免費授予1,843股A類普通股。交易後,Burrell在公司中的直接持股數量增至總共71,254股。該授予是公司股票激勵計劃的一部分,反映了將員工利益與股東利益保持一致的持續承諾。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息